Skip to content

Public FDA record

Z-0211-2020: Beckman Coulter Uric Acid, REF OSR6098, OSR6198, and OSR6698.

Recall record Z-0211-2020 for Beckman Coulter Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0211-2020
Company in FDA record
Beckman Coulter Inc.
FDA record creation date
Oct 24, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

NAPQI, a metabolite of Acetominophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.

Source facts

Action
The recalling firm issued letters dated 8/21/2018 via email or postal mail if an email address was not available on 8/24/2018 to their customers. The letter identified the affected product, problem and actions to be taken. For questions call 1-800-223-0139 in the United States and Canada. Outside the United States and Canada contact local Beckman Coulter Representative.
Initiated
2018-08-24
Root cause
Nonconforming Material/Component
Terminated
2024-08-02
Distribution
Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
Recall number
Z-0211-2020
Recall status
Terminated
CDRH record ID
175793
FDA record created
2019-10-24
Recall event number
83583

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗